Skip to main content
. Author manuscript; available in PMC: 2014 Jul 18.
Published in final edited form as: Arch Dermatol. 2009 Dec;145(12):1391–1396. doi: 10.1001/archdermatol.2009.276

Table 4.

Cox Proportional Hazards Regression Model Summaries for Squamous Cell Carcinoma (SCC) and Basal Cell Carcinoma (BCC) After Heart Transplant and Adjusting for Age and Sex

Variable SCC
BCC
HR (95% CI) P Valuea HR (95% CI) P Valuea
Posttransplantb
 Azathioprine use 0.93 (0.54–1.59) .79 0.55 (0.31–0.97) .03
 Mycophenolate mofetil use 1.05 (0.57–1.94) .86 2.74 (1.50–5.04) .001
 HSV infection 2.90 (1.24–6.77) .01 3.38 (1.32–8.66) .01
 Nonskin cancer 1.80 (1.09–2.99) .02 1.31 (0.70–2.43) .40
HLA mismatches (≥1 vs 0) 0.53 (0.28–0.98) .04 0.72 (0.36–1.45) .36

Abbreviations: CI, confidence interval; HR, hazard ratio; HSV, herpes simplex virus.

a

P ≤ .05 was considered to be statistically significant.

b

Variables measured after transplant are time-dependent predictors.